ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Hao Li
Matched on ORCID iD 0000-0003-1661-7139; OpenAlex author ID A5100348678. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2019: 2 papers · 2020: 1 paper · 2021: 2 papers
Papers 5
- Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal adenocarcinoma. First author DOI 10.1002/ijc.33410↗
- Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. Co-author DOI 10.3390/cancers13153678↗
- TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the Hedgehog signaling pathway. Co-author DOI 10.1038/s41388-020-01407-8↗
- Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma. First author DOI 10.1002/cam4.2430↗
- Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.ejso.2018.10.539↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Huaxiang Xu · 5 shared papers, 2019–2021 · strength 0.48
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. DOI 10.3390/cancers13153678↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Xianjun Yu · 5 shared papers, 2019–2021 · strength 0.48
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. DOI 10.3390/cancers13153678↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Heli Gao · 4 shared papers, 2019–2021 · strength 0.40
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. DOI 10.3390/cancers13153678↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Wuhu Zhang · 4 shared papers, 2019–2021 · strength 0.40
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. DOI 10.3390/cancers13153678↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Wenquan Wang · 4 shared papers, 2019–2021 · strength 0.40
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. DOI 10.3390/cancers13153678↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Shuo Li · 4 shared papers, 2019–2021 · strength 0.38
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Paper Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma. DOI 10.1002/cam4.2430↗
- Chuntao Wu · 4 shared papers, 2019–2021 · strength 0.38
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Paper Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma. DOI 10.1002/cam4.2430↗
- Xuan Han · 3 shared papers, 2020–2021 · strength 0.31
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21. DOI 10.3390/cancers13153678↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Liang Liu · 3 shared papers, 2019–2021 · strength 0.30
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Paper Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma. DOI 10.1002/cam4.2430↗
- Tianjiao Li · 3 shared papers, 2019–2021 · strength 0.30
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Paper Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma. DOI 10.1002/cam4.2430↗
- Wang Jiang · 2 shared papers, 2020–2021 · strength 0.21
- Paper Human splenic TER cells: A relevant prognostic factor acting via the artemin-GFRα3-ERK pathway in pancreatic ductal ade… DOI 10.1002/ijc.33410↗
- Paper TET1 downregulates epithelial-mesenchymal transition and chemoresistance in PDAC by demethylating CHL1 to inhibit the H… DOI 10.1038/s41388-020-01407-8↗
- Liang Liu · 2 shared papers, 2019–2021 · strength 0.18
- Jia Dong · 1 shared paper, 2021 · strength 0.10
- Xu Wang · 1 shared paper, 2021 · strength 0.10
- Xuan Lin · 1 shared paper, 2021 · strength 0.10
- Zhenyu Liao · 1 shared paper, 2021 · strength 0.10
- Long‐Yun Ye · 1 shared paper, 2021 · strength 0.10
- Wen-Quan Wang · 1 shared paper, 2019 · strength 0.08
- He-Li Gao · 1 shared paper, 2019 · strength 0.08
- Shuai-Shuai Xu · 1 shared paper, 2019 · strength 0.08
- Shi-Rong Zhang · 1 shared paper, 2019 · strength 0.08
- Jin-Zhi Xu · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.